Genertec Universal Medical Group Company Limited (5UM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Genertec Universal Medical Group Company Limited (5UM) has a cash flow conversion efficiency ratio of -0.085x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.67 Billion ≈ $-1.95 Billion USD) by net assets (€19.69 Billion ≈ $23.01 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genertec Universal Medical Group Company Limited - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Genertec Universal Medical Group Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Genertec Universal Medical Group Company for a breakdown of total debt and financial obligations.
Genertec Universal Medical Group Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genertec Universal Medical Group Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xiangtan Electrochemical Scientific Co Ltd
SHE:002125
|
0.038x |
|
IRB Infrastructure Developers Limited
NSE:IRB
|
0.052x |
|
Hotel101 Global Holdings Corp. Class A Ordinary Shares
NASDAQ:HBNB
|
N/A |
|
ZWSOFT Guangzhou Co Ltd
SHG:688083
|
0.046x |
|
Iluka Resources Limited
F:ILZ
|
0.011x |
|
Sitio Royalties Corp.
NYSE:STR
|
0.026x |
|
Shanghai GenTech Co Ltd
SHG:688596
|
-0.009x |
|
Reit 1
TA:RIT1
|
0.006x |
Annual Cash Flow Conversion Efficiency for Genertec Universal Medical Group Company Limited (2016–2024)
The table below shows the annual cash flow conversion efficiency of Genertec Universal Medical Group Company Limited from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Genertec Universal Medical Group Company (5UM) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €22.87 Billion ≈ $26.74 Billion |
€1.14 Billion ≈ $1.33 Billion |
0.050x | -79.70% |
| 2023-12-31 | €20.37 Billion ≈ $23.81 Billion |
€4.99 Billion ≈ $5.84 Billion |
0.245x | +134.83% |
| 2022-12-31 | €19.70 Billion ≈ $23.03 Billion |
€2.06 Billion ≈ $2.41 Billion |
0.104x | +231.38% |
| 2021-12-31 | €17.62 Billion ≈ $20.60 Billion |
€-1.40 Billion ≈ $-1.64 Billion |
-0.079x | -22.39% |
| 2020-12-31 | €14.97 Billion ≈ $17.50 Billion |
€-971.72 Million ≈ $-1.14 Billion |
-0.065x | +52.13% |
| 2019-12-31 | €13.45 Billion ≈ $15.72 Billion |
€-1.82 Billion ≈ $-2.13 Billion |
-0.136x | +75.72% |
| 2018-12-31 | €10.26 Billion ≈ $11.99 Billion |
€-5.73 Billion ≈ $-6.70 Billion |
-0.559x | +17.76% |
| 2017-12-31 | €7.47 Billion ≈ $8.73 Billion |
€-5.07 Billion ≈ $-5.93 Billion |
-0.679x | -87.46% |
| 2016-12-31 | €6.57 Billion ≈ $7.69 Billion |
€-2.38 Billion ≈ $-2.78 Billion |
-0.362x | -- |
About Genertec Universal Medical Group Company Limited
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the People's Republic of China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; accounts receivable factoring; operating leases; and advisory services. Its… Read more